Your browser doesn't support javascript.
loading
Aripiprazole and Impulse-Control Disorders: A Recent FDA Warning and a Case Report.
Dhillon, Rohan; Bastiampillai, Tarun; Cao, Claudia Z; Eckert, Thomas G; Tibrewal, Prashant.
Affiliation
  • Dhillon R; Cramond Clinic, Department of Psychiatry, The Queen Elizabeth Hospital, Adelaide, Australia.
  • Bastiampillai T; Department of Psychiatry, Flinders University, Adelaide, Australia.
  • Cao CZ; South Australian Health and Medical Research Institute, Adelaide, Australia.
  • Eckert TG; claudia.cao@sa.gov.au.
  • Tibrewal P; Cramond Clinic, Department of Psychiatry, The Queen Elizabeth Hospital, Adelaide, Australia.
Prim Care Companion CNS Disord ; 19(1)2017 Jan 12.
Article in En | MEDLINE | ID: mdl-28102975
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Aripiprazole / Disruptive, Impulse Control, and Conduct Disorders Limits: Adult / Humans / Male Country/Region as subject: America do norte Language: En Journal: Prim Care Companion CNS Disord Year: 2017 Document type: Article Affiliation country: Australia Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Aripiprazole / Disruptive, Impulse Control, and Conduct Disorders Limits: Adult / Humans / Male Country/Region as subject: America do norte Language: En Journal: Prim Care Companion CNS Disord Year: 2017 Document type: Article Affiliation country: Australia Country of publication: United States